GJA1 and cardiac arrhythmia: In this study, the lower incidence of arrhythmia in both estrogen-treated and vildagliptin-treated rats was consistent with the maintained level of p-Cx43 expression in cardiac tissues, whereas the vehicle-treated rats demonstrated higher arrhythmia scores as well as decreased levels of cardiac p-Cx43 expression.